Status:
COMPLETED
Role of Serotonin in Acute and Subacute MDMA Effects
Lead Sponsor:
California Pacific Medical Center Research Institute
Conditions:
MDMA Mechanism of Action
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to measure the effects of MDMA (particularly its emotional effects) and to determine the role of serotonin in these effects. Serotonin is a neurotransmitter, which is a ch...
Eligibility Criteria
Inclusion
- Healthy men or women aged 18 to 50 years
- Experienced with MDMA
Exclusion
- Significant physical or psychiatric illness which might impair the ability to safely complete the study or that might be complicated by the study drugs, including prior seizures (after age 8), history of major depression, or other active neurological disease or clinically significant abnormalities on physical examination or screening laboratory values
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00838305
Start Date
February 1 2009
End Date
August 1 2011
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CPMC Research Institute, St.Luke's Hospital
San Francisco, California, United States, 94110